E‑News Updates

  • March 12, 2019
    Tags: Big Pharma, biologics, biosimilar, Chuck Grassley, CREATES Act, drug cost, drug prices, JC Scott, John Cornyn, Kathy Buto, MedPAC, Mike Braun, Scott Gottlieb
  • March 6, 2019
    Tags: AFL-CIO, AFSCME, Ami Bera, BCBS, Blue Cross Blue Shield, Center for American Progress, Cory Gardner, Doctors for America, Doug Jones, drug prices, Greg Walden, Health Insurance Tax, Jackie Walorski, Jeanne Shaheen, John Barrasso, John Yarmuth, Josh Gottheimer, Justine Handelman, Kenny Merchant, Kyrsten Sinema, medicare for all, obamacare, price gouging, reimbursements, single-payer, tax subsidies, Tim Scott
  • February 26, 2019
    Tags: Alex Azar, Amy Klobuchar, annual report, Brian Frosh, Chuck Grassley, Cory Booker, David Merritt, Health and Human Services, Kamala Harris, Kirsten Gillibrand, Maryland drug pricing, Prescription Drug Affordability Board, price gouging, Robert Neall
  • February 19, 2019
    Tags: Alex Azar, California Governor, Gavin Newsom, Katie Keith, Kevin Brady, Lloyd Doggett, lower drug prices, Medicaid, medicare for all, Rachel Sachs, Ron Wyden, single-payer healthcare
  • February 12, 2019
    Tags: Alex Azar, Amy Klobuchar, Arron Josephson, Chuck Grassley, CREATES Act, Creating and Restoring Equal Access to Equivalent Samples, Dr. Joe Antos, government shutdown, Mark Miller, Mike Lee, Patrick Leahy, Richard Neal, Scott Gottlieb, Scott Whitaker

e-News Archive

Roundtable Activity

  • March 1, 2019
    Tags: drug prices, Lamar Alexander
    The Roundtable has responded to a request from Senator Lamar Alexander (R-TN),Chairman of the Senate Health, Education, Labor, and Pension Committee, seeking specific recommendations to address rising health care costs in the United States. Our response argues the rising cost of health care — especially the rising cost of prescription drugs — severely threatens the […]
  • March 1, 2019
    Tags: drug cost, drug prices, Seema Verma
    In a letter to HHS Secretary Alex Azar and CMS Administrator Seema Verma, the Roundtable described the overwhelming impact the rising cost of prescription drugs is having on Roundtable members and the public sector workers, retirees, and dependents they serve. The letter, which is largely based on data from our annual Pharmacy Survey, offers several policy […]

Activity Archive